Neuralight

Series-A
neuralight.ai Biotech & Healthcare
Total Funding $30.5M
Latest Round $25M Series-A
Last Announced May 24, 2022
Investors Undisclosed
Decision Makers 4 Verified

About Neuralight

Precision biomarkers that quantify functional brain change. Supporting drug development and brain health programs.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Undisclosed
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website neuralight.ai
Domain Registered Date Sep 30, 2020

Social & Network Presence

X / Twitter Profile @NeuraLight (136 followers) Created on Oct 2021
LinkedIn Corporate Not linked

Company Milestones & Timeline

4 Events
  1. Capital Raise

    Raised $25,000,000 · Series-A

    fundraisingfox.com

  2. Capital Raise

    Raised $5,500,000 · Seed

    fundraisingfox.com

  3. Milestone

    X account created (@NeuraLight)

    136 followers

  4. Milestone

    Website domain registered

    neuralight.ai

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Neuralight.

Funding History

2 Rounds
Series-A · May 24, 2022
Seed · Oct 28, 2021

Founders & Leadership

3

Edmund Ben Ami

Founder

Work email & phone locked Unlock →

Gil Shklarski

Founder

Work email & phone locked Unlock →

Thomas C. Südhof

Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts